Stability of phenotypes defined by physiological variables and biomarkers in adults with asthma

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 69, Issue 9, 2014, Pages 1198-1204

  Kupczyk, M ^a,b   Dahlen B ^a   Sterk, P J ^c   Nizankowska Mogilnicka, E ^d   Papi, A ^e   Bel, E H ^c   Chanez, P ^f   Howarth, P H ^g   Holgate, S T ^g   Brusselle, G ^h   Siafakas, N M ⁱ   Gjomarkaj, M ^j   Dahlen S E ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF AMSTERDAM   (Netherlands)

^d JAGIELLONIAN UNIVERSITY   (Poland)

^e UNIVERSITY OF FERRARA   (Italy)

^f AIX MARSEILLE UNIVERSITY   (France)

^g UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ UNIVERSITY OF CRETE   (Greece)

^j CNR   (Italy)

more..

Author keywords

asthma; biomarkers; eosinophils; lung functions; stability of phenotypes

Indexed keywords

ANTIASTHMATIC AGENT; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AGED; ALGORITHM; ASTHMA; CLASSIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; EOSINOPHIL; FEMALE; HUMAN; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; LONGITUDINAL STUDY; LUNG FUNCTION TEST; MALE; MIDDLE AGED; NEUTROPHIL; PHENOTYPE; RANDOMIZED CONTROLLED TRIAL; SPUTUM; YOUNG ADULT;

ADMINISTRATION, INHALATION; ADOLESCENT; ADULT; AGED; ALGORITHMS; ANTI-ASTHMATIC AGENTS; ASTHMA; BIOMARKERS; COHORT STUDIES; DOUBLE-BLIND METHOD; EOSINOPHILS; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUTROPHILS; PHENOTYPE; RESPIRATORY FUNCTION TESTS; SPUTUM; YOUNG ADULT;

EID: 84905819945     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.12445     Document Type: Article

References (24)

1. Wenzel SE,. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012; 18: 716-725.
2. Kupczyk M, Wenzel SE,. US and European severe asthma cohorts: what can they teach us about severe asthma? J Intern Med 2012; 272: 121-132.
3. Woodruff PG, Modrek B, Choy DF, Jia G, Abbas AR, Ellwanger A, et al. T-helper type 2-driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med 2009; 180: 388-395.
4. Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med 2008; 178: 218-224.
5. Hastie AT, Moore WC, Meyers DA, Vestal PL, Li H, Peters SP, et al. Analyses of asthma severity phenotypes and inflammatory proteins in subjects stratified by sputum granulocytes. J Allergy Clin Immunol 2010; 125: 1028-1036.
6. Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med 2010; 181: 315-323.
7. Green RH, Pavord I,. Stability of inflammatory phenotypes in asthma. Thorax 2012; 67: 665-667.
8. Kupczyk M, Haque S, Sterk PJ, Niżankowska-Mogilnicka E, Papi A, Bel EH, et al. Detection of exacerbations in asthma based on electronic diary data-results from the 1-year prospective BIOAIR study. Thorax 2013; 68: 611-618.
9. Kupczyk M, ten Brinke A, Sterk PJ, Bel EH, Papi A, Chanez P, et al. Frequent exacerbators-A distinct phenotype of severe asthma. Clin Exp Allergy 2014; 44: 212-221.
10. Fleming L, Tsartsali L, Wilson N, Regamney N, Bush A,. Sputum inflammatory phenotypes are not stable in childdren with asthma. Thorax 2012; 67: 675-681.
11. Pizzichini E, Pizzichini MM, Efthimiadis A, Evans S, Morris MM, Squillace D, et al. Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. Am J Respir Crit Care Med 1996; 154: 308-317.
12. Simpson JL, McElduff P, Gibson PG,. Assessment and reproducibility of non-eosinophilic asthma using induced sputum. Respiration 2010; 79: 147-151.
13. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, et al. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care Med 2012; 185: 612.
14. Global Initiative for Asthma. Global strategy for asthma management and prevention 2008. Available on-line at www.ginasthma.com.
15. The ENFUMOSA cross-sectional European multicentre study of the clinical phenotype of chronic severe asthma. The ENFUMOSA Study Group. Eur Respir J 2003; 22: 470-477.
16. Berry M, Morgan A, Shaw DE, Parker D, Green R, Brightling C, et al. Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma. Thorax 2007; 62: 1043-1049.
17. van Veen IH, ten Brinke A, Gauw SA, Sterk PJ, Rabe KF, Bel EH,. Consistency of sputum eosinophilia in difficult-to-treat asthma: a 5-year follow-up study. J Allergy Clin Immunol 2009; 124: 615-617.
18. Simpson JL, Scott R, Boyle MJ, Gibson PG,. Inflammatory subtypes in asthma: assessment and identification using induced sputum. Respirology 2006; 11: 54-61.
19. Gibson PG, Simpson JL, Saltos N,. Heterogeneity of airway inflammation in persistent asthma: evidence of neutrophilic inflammation and induced sputum interleukin-8. Chest 2001; 119: 1329-1336.
20. Al-Samri M, Benedetti A, Prefontaine D, Olivenstein R, Lemiere C, Nair P, et al. Variability of sputum inflammatory cells in asthmatic patients receiving corticosteroid therapy: a prospective study using multiple samples. J Allergy Clin Immunol 2010; 125: 1161-1163.
21. Green RH, Brightling CE, McKenna S, Hargadon B, Parker D, Bradding P, et al. Asthma exacerbations and sputum eosinophil counts: a randomized controlled trial. Lancet 2002; 360: 1715-1721.
22. Hruby J, Butler J,. Variability of routine pulmonary function tests. Thorax 1975; 30: 548-553.
23. Bousquet J, Mantzouranis E, Cruz AA, Ait-Khaled N, Baena-Cagnani CE, Bleecker ER, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
24. Chung KF, Wenzel SE, Brozek JL, Bush A, Castro M, Sterk PJ, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J 2014; 43: 343-373.